scholarly journals Prevalence of canine Parvo virus infection in street dogs using rapid antigen detection Kit

2015 ◽  
Vol 2 (3) ◽  
pp. 459-464
Author(s):  
Faizul Wasima Nahat ◽  
Md Siddiqur Rahman ◽  
Roma Rani Sarker ◽  
Md Kumrul Hassan ◽  
AKM Zeaul Hasan ◽  
...  

Canine parvovirus is one of the most common infectious diseases of dogs. A study was carried out to diagnose the infection of canine parvovirus in street dogs from different places of Mymensingh Town. Rectal samples were collected from January to April, 2015. A total of 114 rectal swabs were collected conveniently from street dogs of Mymensingh. The samples were diagnosed using RapiGEN Canine Parvo Virus Ag Test Kit. The association of CPV infection with demographic variables was assessed by Chisquare test. The overall prevalence of CPV was 32.0% in dogs. The prevalence of parvovirus infection was found to be significantly higher in puppies and 6 months of age (58.3%) than those >24 months of age (p=0.005). The prevalence of canine parvovirus infection also varied significantly in different study area (p=0.003). The prevalence of canine parvovirus infection was higher in male (34.4%) than that in female (30.2%) but it was not statistically significant.Res. Agric., Livest. Fish.2(3): 459-464, December 2015

2016 ◽  
Vol 2 (1) ◽  
pp. 138-142 ◽  
Author(s):  
Soumitra Sen ◽  
Md Siddiqur Rahman ◽  
Minakshi Nag ◽  
Mohummad Muklesur Rahman ◽  
Roma Rani Sarker ◽  
...  

Canine parvovirus (CPV) and canine influenza virus (CIV) are highly contagious virus infecting members of the canine family including dogs, coyotes, foxes and wolves. The research work was carried out to determine the prevalence of CPV and CIV in dogs (stray and pet dogs) in Dhaka, Mymensingh, Feni and Chittagong Districts by using Rapigen CPV and CIV Ag test kit. Fecal samples were collected from 50 dogs of different age and sex from different spots of Dhaka and Chittagong District. Nasal fluid samples were collected from 50 dogs of different age and sex from different spots. The samples were tested with Rapigen canine parvovirus Ag test kit and Rapigen canine influenza Ag test kit. Overall prevalence of CPV in pet dogs was 22% and in stray dogs was 30%. The prevalence of canine parvovirus in relation to age was gradually decreasing with higher age group and the prevalence was 28% in 1-6 months age, 16.66% in 7-12 months age group 11.11%o ver 18 months age group. The prevalence of canine parvovirus was significantly higher in male (24.13%) than that in female (19.04%). All samples showed negative test result for canine influenza virus. Prevalence of canine influenza virus infection were 00.00% in all age groups and sex. Overall prevalence of CIV in all pet and stray dogs were 00.00%.Asian J. Med. Biol. Res. March 2016, 2(1): 138-142


Author(s):  
Felix K. Shima ◽  
Fidelis A. Gberindyer ◽  
Matthew T. Tion ◽  
Olusegun A. Fagbohun ◽  
Temidayo O. Omobowale ◽  
...  

2008 ◽  
Vol 2 (8) ◽  
pp. e280 ◽  
Author(s):  
Philippe Dussart ◽  
Laure Petit ◽  
Bhety Labeau ◽  
Laetitia Bremand ◽  
Alexandre Leduc ◽  
...  

2020 ◽  
Vol 7 (5) ◽  
pp. 804
Author(s):  
Rakesh K. Yadav ◽  
Raj K. ◽  
Kachnar V. ◽  
Manoj K. Mathur ◽  
Amitabh D. Shukla

Background: Anti-cyclic citrullinated peptide (anti-CCP) antibodies have been considered very specific for rheumatoid arthritis (RA). Some studies have shown that these antibodies can be positive in infectious diseases like tuberculosis, human immunodeficiency virus infection, etc.Methods: Eighty patients of tuberculosis both pulmonary and extra-pulmonary tuberculosis and thirty patients of human immunodeficiency virus were enrolled in this study from inpatient and outpatient departments from September 2018 to August 2019. Anti-CCP antibody test was done in all the patient by enzyme linked immunosorbent assay.Results: Fifty-three patients were of pulmonary tuberculosis, 27 patients were extra-pulmonary tuberculosis and 30 patients were human immunodeficiency virus infection. Of the 53 cases of pulmonary tuberculosis, 21 (39.6%) cases were positive for anti-CCP antibodies and 32 (60.4%) cases were negative for the same. Of the 27 cases of extra-pulmonary tuberculosis, 3(11.1%) cases were positive for anti-CCP antibodies and 24 (88.9%) cases were negative. Of the 53 patients of pulmonary tuberculosis, 16 were sputum positive and 37 were sputum negative. Of those withsputum positive 9 (56.2%) cases were positive for anti-CCP antibodies and those with sputum negative, 12 (32.4%) cases were positive for anti-CCP antibodies. Of the 30 cases of human immunodeficiency virus, 5 (16.7%) cases were positive for anti-CCP antibodies and 25 (83.3%) cases were negative.Conclusions: Anti-CCP can be positive in cases of infectious diseases like tuberculosis and human immunodeficiency virus. Positivity of anti-CCP antibodies for tuberculosis is more for pulmonary (more for sputum-positive than sputum-negative) than extra-pulmonary tuberculosis. Anti-CCP, thus is not very specific for rheumatoid arthritis.


2019 ◽  
Vol 6 (Supplement_2) ◽  
pp. S912-S912
Author(s):  
Nicole Titze ◽  
Jasjit Singh ◽  
Wendi Gornick

Abstract Background Many emergency departments and urgent care settings use the commonly available Respiratory Syncytial Virus Rapid Antigen Detection Test (RSV RADT) to diagnose children with RSV. We noted discordant results between RADT and definitive testing. Our study looked at the positive predictive value (PPV) and the false discovery rate (FDR) of the RSV RADT at our facility. Methods We pro- and retrospectively reviewed all patients with positive RSV RAPD tests from July 1, 2017 through March 31, 2019. The test utilized was the QuickVue® RSV Test Kit (QUIDEL Corp, CA, USA), which detects the viral fusion protein present in RSV. Of the tests performed, we chose patients who had definitive testing with either a direct fluorescent antibody (DFA) or a polymerase chain reaction (PCR). We then calculated the PPV as well as the FDR of the RSV RADT during the total interval period, as well as off-season periods (April 1 through October 31) and in-season periods (November 1 through March 31). Results During the study period there were 1128 RSV RADT tests performed, of which 232 had definitive testing with either DFA or PCR (Figures 1 and 2). We found the overall PPV during the study period was 63.3%. During the off-season 30 positive RSV RADT received definitive testing, of which 6 were positive, which yields a PPV of only 20%. In season, 202 RSV RADT received additional testing with 141 positive for RSV. The PPV was 69.8%. The FDR correlated with 36.7% throughout the entire studied period, 80% during the off-season and 30.2% during in-season. As expected, the PPV was higher during times of higher prevalence (Figure 3). Conclusion Based on our results, utilization of the RSV RADT during time of low prevalence yields a high false detection rate and should therefore be discouraged. The use during times of high prevalence yields only modest results and is unlikely to aid in clinical decision-making. Our results differ from those published by the manufacturer (PPV 84%), and may reflect differences in sample collection in the acute care setting. Disclosures All authors: No reported disclosures.


2017 ◽  
Vol 52 (9) ◽  
pp. 1345-1346 ◽  
Author(s):  
J Styczynski ◽  
J Hoek ◽  
N Knelange ◽  
M Mikulska ◽  
S Cesaro ◽  
...  

While infections have always played an important role in the history of mankind, advances in science and technology as well as rapid globalization have resulted in an unprecedented wave of new and old infections thrust into the limelight. The recent pandemic of H1N1 influenza virus infection demonstrates the recurrent theme of emerging and reemerging pathogens that continue to impact public health and patient care areas. Drug resistance among various organisms (not limited to bacteria) has unfortunately become the expectation and, not infrequently, we have been left with few or no efficacious treatment options, an experience not witnessed in more than 7 decades. Human immunodeficiency virus infection continues to challenge our abilities to provide the desired level of care in most areas of the world. Novel syndromes of infection continue to be defined as newer forms of immunosuppression and the development of unique medical devices become standard practice in all areas of medicine and surgery. For trainees and practitioners in the field of infectious diseases today, these factors mandate intense study to establish an expertise in the field that is required to provide best practices now and beyond. This board review will be pivotal in that education. This book is designed and intended primarily for infectious diseases trainees and practitioners preparing for the infectious disease subspecialty examination of the American Board of Internal Medicine. We believe that this book will also be useful to infectious diseases practitioners as well as general internists and other clinicians who desire a comprehensive but practical overview of contemporary infectious diseases topics.


Sign in / Sign up

Export Citation Format

Share Document